在瘤中EBV编码和EBV相关的miRNA的影响
Prankur Awasthi1, Arjun Singh Kohli1, Manish Dwivedi1
1Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow-226028, India.
Current gene therapy
|January 10, 2025
概括
爱普斯坦-巴尔病毒 (EBV) 编码促进癌症的微RNA (miRNA). 针对这些EBV-miRNA的新疗法,如miRNA海绵和CRISPR/Cas9,显示出治疗EBV相关恶性瘤的前景.
科学领域:
- 病毒学 病毒学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 爱斯坦-巴尔病毒 (EBV) 感染了全球90%以上的人口.
- EBV与多种癌症有关,包括淋巴瘤和胃癌.
- EBV是第一个编码微RNAs (miRNAs) 的病毒,对于病毒的持续性和免疫规避至关重要.
研究的目的:
- 为了探索EBV编码的miRNAs的亲致癌作用.
- 审查最近基于miRNA的诊断和治疗EBV相关癌症的进展.
- 突出在癌症治疗中准EBV小RNA的潜力.
主要方法:
- 分析EBV编码的miRNAs,包括BHRF1miRNAs和BARTmiRNAs.
- 对鉴定miRNA分子标的体外研究进行审查.
- 检查体内研究,阐明miRNA在EBV感染中的病理生理学.
主要成果:
- 编码EBV的miRNA显著影响EBV相关瘤的生长.
- 特定的EBV小RNAs (BHRF1miRNA,BART miRNAs) 对病毒感染和宿主防御逃避至关重要.
- 了解miRNA目标及其在癌症发展中的作用的进展.
结论:
- 针对EBV miRNAs为EBV相关的恶性瘤提供了一个有前途的治疗策略.
- 像miRNA海绵,抗miRNA寡核酸和CRISPR/Cas9这样的新兴技术正在迅速发展.
- 这些创新预示着治疗EBV相关癌症的新时代.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K


